Kevin Bassett

Kevin Bassett has over twenty years of experience in the medical device industry. Kevin is currently the President and CEO of InSitu Biologics, a position they have held since August 2019. Prior to this, Kevin was the General Manager at HLT, where they managed the Transcatheter Heart Valve Business Unit. Kevin has also held Senior Vice President positions at Acorn Cardiovascular and Sunshine Heart, where they were responsible for R&D, Operations, and Quality Assurance. Kevin is a Co-Founder of St. Paul Consulting, where they served as President and CEO from May 1997 to December 2003.

Kevin Bassett received a Bachelor of Science in Accounting and English from Saint John's University. Kevin then went on to earn a Master of Business Administration in Operations Management and Supervision from the University of Minnesota - Carlson School of Management. Kevin Bassett also attended the United States Air Force Academy.

Some direct reports include Bill Taylor - Chief Science Officer, Kevin Barrett - Chief Operating Officer, and Mark Ereth - Chief Medical Officer.